This article was originally published Jan. 21.
Febit said last week that the molecular genetics core facility at Children's Hospital Boston will use its Geniom RT Analyzer for targeted resequencing with the company's HybSelect technology.
The core facility, which is scheduled to receive the instrument later this month, plans to use the HybSelect technology in conjunction with its Applied Biosystems SOLiD platform.
"The ease and flexibility of HybSelect allows us to study a variety of genetic diseases and multiplex bar-coded libraries, making sequence-capture projects much more accessible and affordable to our investigators," said Hal Schneider, manager of the facility, in a statement issued by Febit.
Febit CSO Peer Stähler said that the company is working on a set of 96 barcodes for HybSelect, which will enable scientists to sequence up to 2,304 samples in six days.
Last year, the firm struck a co-marketing agreement with Life Technologies and installed two SOLiD instruments at its Heidelberg location (see In Sequence 9/29/2009).